People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| C3J Therapeutics, Inc. | — | Biotechnology | Series B | $19.0M | $754.1M | 2016 |
LAURA R. CZELADA at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside LAURA R. CZELADA on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| H. Stewart Parker | 1 | 2 |
| TODD R. PATRICK | 1 | 2 |
| JAMES R. GARRISON | 1 | 1 |
| RICHARD R. BASTIANI | 1 | 1 |
| WENYUAN R. SHI | 1 | 1 |
| RICHARD STEWART BISSON | 1 | 1 |
| STEVEN R. SEMMELMAYER | 1 | 1 |
| FREDERICK R. EICHMILLER | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.